Denosumab injection: Treatment of increased bone mass in females with breast cancer
Created 1 month ago by marykudro

Denosumab is sold under the brand name Prolia and used to treat several bone-related problems, e.g., patients with osteoporosis, patients with increased bone mass having breast cancer, etc. It comes in the form of a single-use vial of strength 60 mg.
The active ingredients in Denosumab 60 mg injection are sorbitol, acetate, polysorbate 20, water, and sodium hydroxide. The general dosage for the medicine is 60 mg every 6 months administered subcutaneously in the upper arm, upper thigh, or abdomen.